CYTORI THERAPEUTICS INC DEF14A 8-16-2012

Company

PLUS THERAPEUTICS, INC.

Filed

April 30, 2012

Period of Report

August 16, 2012

Accession Number

0001095981-12-000007

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →